Nuclear fusion. People on Mars. Artificial general intelligence. These are just some of the advances that could come by the ...

New York City is investing over $1 billion to become a global leader in the life sciences — and at the heart of that mission is a commitment to infrastructure, innovation, and equity. In this episode, ...

Texas’s premier life science conference returns to Houston in November, spotlighting breakthrough innovations in therapeutics, medical technology, and digital health. HOUSTON--(BUSINESS WIRE)--Rice ...

Life sciences is standing on the edge of its most consequential decade. Scientific discovery is advancing at breakneck speed—cell and gene therapies, advanced biologics, precision diagnostics—all ...

In the modern landscape of personalized diagnostics, drug research, development, and manufacturing, data integrity and velocity of the product-to-market are everything. A key player driving the ...

From therapeutic complexity, FDA regulatory policy changes, geopolitical shocks and an AI race, life sciences supply chain leaders are forced to rewrite their playbook to stay relevant in the era of ...

Registration Questions? **Please note we have pricing tiers based on ticket availability. Ticket prices will increase once we sell out of the current pricing tier. We cannot redeem a lower price once ...

In November, GlioCART, a CAR-T therapeutics spinout from the University of Basel became the latest example of the continuing ...

Registration Questions? **Please note we have pricing tiers based on ticket availability. Ticket prices will increase once we sell out of the current pricing tier. We cannot redeem a lower price once ...

CHENNAI: The life sciences industry — one of the most sophisticated yet highly regulated sectors — has always been on its toes, striving to improve operations and create new value to meet ...

Editor’s note (May 19th 2025): On May 16th, MIT said that Aidan Toner-Rodgers was no longer in the MIT PhD program. The university “has no confidence in the provenance, reliability or validity of the ...

Future Fields CEO Matt Anderson-Baron shares the raw lessons and hard pivots behind building a biotech company during Life Sciences Week in Edmonton. Matt Anderson-Baron is the CEO of Future Fields. - ...